Exor, led by Fiat brand heirs the Agnelli family, has signed a partnership agreement for an investment of EUR 833 million in the also family-owned…

After decades of investment, Catalonia has secured its healthcare and life sciences hub status, accounting for more than half of Spain’s pharma…

The latest healthcare and pharma news from Taiwan, including the CDMO Bora Pharmaceutical's acquisition of Eden Biologics assets, the FDA fast track…

Accord’s Marc Comas highlights the company’s presence in Spain with leading oncology products, three biosimilars and investment in specialty…

The executive president of Laboratorios Rubió, Carlos Rubió, analyses the fundamentals behind the Catalan company’s double-digit growth, its…

One of the more intriguing aspects about the new wave of cell and gene therapies (CGT) coming onstream is that they are not just technologically…

Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park explores new ways of virtual collaboration that make our lives easier while…

During a global virtual press briefing on 19 March 2020, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)…

Barbara Lopez Kunz, CEO of the Drug Information Association (DIA) in the USA, outlines the association’s four key areas of focus – regulatory…

GemPharmatech is a fast-growing service center for production, distribution and phenotyping of gene-modified mouse models with multiple subsidiaries…

HRP Labs, the largest operator of pathology and specialized laboratories in Puerto Rico, is leading the way in the post-Hurricane Maria industry.…

With sustainable development goals in mind, the global umbrella pharmaceutical association IFPMA has recently launched a platform that fosters…